DRUG · Mapped RxNorm record
Dupilumab
Normalized identity: dupilumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
NCT02414854
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Inhaled corticosteroid (ICS) therapy
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Albuterol/Salbutamol
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Levalbuterol/Levosalbutamol
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
DupilumabDRUG · verified · RxNorm: dupilumab
PlaceboDRUG
Sponsors & collaborators
Sanofilead sponsor
Regeneron Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02414854 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.